Celyad Oncology SA: Celyad Oncology: Letter to Shareholders

Regulatory News: Celyad Oncology SA (Brussels:CYAD) (Paris:CYAD) (NASDAQ:CYAD): Dear Shareholder, 2022 has been a crossroad year for Celyad Oncology (the "Company"), with important changes and

Related Keywords

Mont Saint Guibert ,Waals Gewest ,Belgium ,New York ,United States ,Paris ,France General ,France ,Dennis Riedl ,Van Lanschot Kempen ,Hilde Windels ,Filippo Petti ,Michel Lussier ,Celyad Oncology The Company ,Propharma Group Holdings ,Regulatory News ,Celyad Oncology ,Cell Therapy Manufacturing Unit ,Ncardia Belgium ,Celyad ,Ncology ,Setter ,Shareholders ,